New study aims to sharpen prognosis tools for rare blood cancer

NCT ID NCT05911802

Recruiting now Knowledge-focused Sponsor: French Innovative Leukemia Organisation Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at 500 people with Waldenström macroglobulinemia, a rare blood cancer, to check how well current scoring systems predict survival and treatment response. Researchers will track patients over time, including those without symptoms, to refine these tools. The goal is to help doctors make better treatment decisions and design faster clinical trials for new therapies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better predict disease progression and tailor treatments for Waldenström patients, potentially improving survival and quality of life.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly provide new therapies. Results may not apply to all patient groups or lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Waldenstrom macroglobulinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROGNOSTIC INDEX WALDENSTROM'S DISEASE

Contacts and locations

Locations

AMIENS - CH Amiens Picardie Site Sud
NOT_YET_RECRUITING

Amiens, 80054, France
APHP - Hôpital Pitié Salpêtrière - Hématologie
NOT_YET_RECRUITING

Paris, 75651, France
Angers Chu
NOT_YET_RECRUITING

Angers, 49933, France
Clermont-Ferrand - Chu Estaing
NOT_YET_RECRUITING

Clermont-Ferrand, 63000, France
Institut Bergonie
NOT_YET_RECRUITING

Bordeaux, 33076, France
Institut Paoli Calmette
NOT_YET_RECRUITING

Marseille, 130009, France
LENS - GHT Artois
NOT_YET_RECRUITING

Lens, 62300, France
LIBOURNE - Hôpital Robert Boulin
NOT_YET_RECRUITING

Libourne, 33505, France
LILLE GHICL - Hôpital Saint Vincent de Paul
RECRUITING

Lille, 59000, France
Le Mans CH
NOT_YET_RECRUITING

Le Mans, France
POITIERS - Hématologie et Thérapie Cellulaire
NOT_YET_RECRUITING

Poitiers, 86021, France
Reims Chu
NOT_YET_RECRUITING

Reims, 51092, France
Strasbourg - Icans
NOT_YET_RECRUITING

Strasbourg, 67033, France
Toulouse - IUCT Oncopole - Service d'Hématologie
NOT_YET_RECRUITING

Toulouse, 31059, France
VERSAILLES - Hôpital André Mignot
NOT_YET_RECRUITING

Versailles, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.